Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial investigates contrast-enhanced mammography (CEM) in detecting breast
cancer. CEM is similar to standard mammography, but it includes an injection of an
iodine-based contrast, which makes tissue and blood vessels more visible in scans. Diagnostic
procedures, such as CEM, may increase the chance of finding breast cancers and decrease the
risk of having unnecessary biopsies.